Evidence map›Paper›PMID 30718881›Full record

ArticleNature biotechnology2019

Capturing sequence diversity in metagenomes with comprehensive and scalable probe design.

Hayden C Metsky, Katherine J Siddle, Adrianne Gladden-Young, James Qu, David K Yang, Patrick Brehio, Andrew Goldfarb, Anne Piantadosi, Shirlee Wohl, Amber Carter and 38 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07626073 (h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.), which is not on this map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07626073 enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.

Typeobservational_patient_registrySponsorChina Medical University HospitalRan2023 to 2028Enrolled200ConditionsRespiratory Pathogens
3 · Its place in the literature

Who cites it

108 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Enrichment techniques for clinical metagenomics.Frontiers in cellular and infection microbiology · 2026
    Review
  14. Article
  15. Article
  16. InvestigatingbioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Hayden C MetskyBroad Institute of MIT and Harvard, Cambridge, MA, USA. hayden@mit.edu.ORCID http://orcid.org/0000-0002-8871-2349
Katherine J SiddleBroad Institute of MIT and Harvard, Cambridge, MA, USA. kjsiddle@broadinstitute.org.
Adrianne Gladden-YoungBroad Institute of MIT and Harvard, Cambridge, MA, USA.
James QuBroad Institute of MIT and Harvard, Cambridge, MA, USA.
David K YangBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9972-3035
Patrick BrehioBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Andrew GoldfarbFaculty of Arts and Sciences, Harvard University, Cambridge, MA, USA.
Anne PiantadosiBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Shirlee WohlBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Amber CarterBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Aaron E LinBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7400-4125
Kayla G BarnesBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Damien C TullyThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Bjӧrn CorleisThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Scott HenniganMassachusetts Department of Public Health, Boston, MA, USA.
Giselle Barbosa-LimaFundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
Yasmine R VieiraFundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
Lauren M PaulDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, USA.ORCID http://orcid.org/0000-0001-5503-7570
Amanda L TanDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, USA.
Kimberly F GarciaInstituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Leda A ParhamInstituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Ikponmwosa OdiaInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Philomena EromonAfrican Center of Excellence for Genomics of Infectious Disease (ACEGID), Redeemer's University, Ede, Nigeria.
Onikepe A FolarinAfrican Center of Excellence for Genomics of Infectious Disease (ACEGID), Redeemer's University, Ede, Nigeria.
Augustine GobaLassa Fever Laboratory, Kenema Government Hospital, Kenema, Sierra Leone.
Viral Hemorrhagic Fever Consortium
Etienne Simon-LorièreEvolutionary Genomics of RNA Viruses, Virology Department, Institut Pasteur, Paris, France.
Lisa HensleyIntegrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Frederick, MD, USA.
Angel BalmasedaLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Douglas S KwonDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Todd M AllenThe Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Jonathan A RunstadlerDepartment of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA, USA.
Sandra SmoleMassachusetts Department of Public Health, Boston, MA, USA.
Fernando A BozzaFundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
Thiago M L SouzaFundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
Sharon IsernDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, USA.
Scott F MichaelDepartment of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, USA.
Ivette LorenzanaInstituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Lee GehrkeInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Irene BoschInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gregory EbelDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Donald S GrantLassa Fever Laboratory, Kenema Government Hospital, Kenema, Sierra Leone.ORCID http://orcid.org/0000-0002-4329-0795
Christian T HappiDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Daniel J ParkBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Andreas GnirkeBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Pardis C SabetiBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Christian B MatrangaBroad Institute of MIT and Harvard, Cambridge, MA, USA.

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI BIRREN, BRUCE W., NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Utilize Microbial Metagenomics for Viral Pathogen CharacterizationU54HG007480 · NHGRI · REDEEMER'S UNIVERSITY · PI HAPPI, CHRISTIAN T. · 2017 to 2022
$5.5M
Design of a human monoclonal antibody-informed dengue vaccineR01AI099210 · NIAID · FLORIDA GULF COAST UNIVERSITY · PI ISERN, SHARON · 2013 to 2016
$1.7M
Host and Microbial Genetic Determinants of Febrile Illness in West AfricaU01HG007480 · NHGRI · REDEEMER'S UNIVERSITY · PI HAPPI, CHRISTIAN T. · 2013 to 2016
$1.6M
NHGRI NIH HHS U01 HG007480NHGRI NIH HHS U54 HG007480NIAID NIH HHS HHSN272200900049CNIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI099210NIAID NIH HHS T32 AI007061NIAID NIH HHS U19 AI110818
6 · The paper itself

Abstract

Metagenomic sequencing has the potential to transform microbial detection and characterization, but new tools are needed to improve its sensitivity. Here we present CATCH, a computational method to enhance nucleic acid capture for enrichment of diverse microbial taxa. CATCH designs optimal probe sets, with a specified number of oligonucleotides, that achieve full coverage of, and scale well with, known sequence diversity. We focus on applying CATCH to capture viral genomes in complex metagenomic samples. We design, synthesize, and validate multiple probe sets, including one that targets the whole genomes of the 356 viral species known to infect humans. Capture with these probe sets enriches unique viral content on average 18-fold, allowing us to assemble genomes that could not be recovered without enrichment, and accurately preserves within-sample diversity. We also use these probe sets to recover genomes from the 2018 Lassa fever outbreak in Nigeria and to improve detection of uncharacterized viral infections in human and mosquito samples. The results demonstrate that CATCH enables more sensitive and cost-effective metagenomic sequencing.

Indexed as

Genome, ViralMetagenomeMetagenomicsAnimalsComputational BiologyCulicidaeDisease OutbreaksGene LibraryGenetic VariationGenomicsHigh-Throughput Nucleotide SequencingHumansLassa FeverNigeriaOligonucleotide ProbesOligonucleotidesOligonucleotide ProbesOligonucleotides

Identifiers

PMID30718881
PMCPMC6587591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.